INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Instituto de Biomedicina y Biotecnología de Cantabria
Santander, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biomedicina y Biotecnología de Cantabria (8)
2019
-
Altered gene expression in antipsychotic-induced weight gain
npj Schizophrenia, Vol. 5, Núm. 1
-
Sex differences in gene expression related to antipsychotic induced weight gain
PLoS ONE, Vol. 14, Núm. 4
2018
-
Blood gene expression profile predicts response to antipsychotics
Frontiers in Molecular Neuroscience, Vol. 11
2016
-
Absence of K-Ras Reduces Proliferation and Migration But Increases Extracellular Matrix Synthesis in Fibroblasts
Journal of Cellular Physiology, Vol. 231, Núm. 10, pp. 2224-2235
-
Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease
Neurobiology of Aging, Vol. 38, pp. 214.e1-214.e5
2015
-
Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls
Neurobiology of Aging, Vol. 36, Núm. 2, pp. 1105-1109
2014
-
Schizophrenia gene expression profile reverted to normal levels by antipsychotics
International Journal of Neuropsychopharmacology, Vol. 18, Núm. 4, pp. 1-7
2012
-
Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin
Journal of Biological Chemistry, Vol. 287, Núm. 32, pp. 26495-26505